GB9015108D0 - Chemical compositions - Google Patents

Chemical compositions

Info

Publication number
GB9015108D0
GB9015108D0 GB909015108A GB9015108A GB9015108D0 GB 9015108 D0 GB9015108 D0 GB 9015108D0 GB 909015108 A GB909015108 A GB 909015108A GB 9015108 A GB9015108 A GB 9015108A GB 9015108 D0 GB9015108 D0 GB 9015108D0
Authority
GB
United Kingdom
Prior art keywords
chemical compositions
compositions
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB909015108A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ed Geistlich Soehne AG fuer Chemische Industrie
Original Assignee
Ed Geistlich Soehne AG fuer Chemische Industrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ed Geistlich Soehne AG fuer Chemische Industrie filed Critical Ed Geistlich Soehne AG fuer Chemische Industrie
Priority to GB909015108A priority Critical patent/GB9015108D0/en
Publication of GB9015108D0 publication Critical patent/GB9015108D0/en
Priority to JP51135891A priority patent/JP3465824B2/ja
Priority to EP91911804A priority patent/EP0491018A1/en
Priority to PCT/EP1991/001269 priority patent/WO1992000743A1/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
GB909015108A 1990-07-09 1990-07-09 Chemical compositions Pending GB9015108D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB909015108A GB9015108D0 (en) 1990-07-09 1990-07-09 Chemical compositions
JP51135891A JP3465824B2 (ja) 1990-07-09 1991-07-08 腫瘍治療用医薬組成物
EP91911804A EP0491018A1 (en) 1990-07-09 1991-07-08 Use of taurolidine and/or taurultam for the treatment of tumours
PCT/EP1991/001269 WO1992000743A1 (en) 1990-07-09 1991-07-08 Use of taurolidine and/or taurultam for the treatment of tumours

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909015108A GB9015108D0 (en) 1990-07-09 1990-07-09 Chemical compositions

Publications (1)

Publication Number Publication Date
GB9015108D0 true GB9015108D0 (en) 1990-08-29

Family

ID=10678847

Family Applications (1)

Application Number Title Priority Date Filing Date
GB909015108A Pending GB9015108D0 (en) 1990-07-09 1990-07-09 Chemical compositions

Country Status (4)

Country Link
EP (1) EP0491018A1 (ja)
JP (1) JP3465824B2 (ja)
GB (1) GB9015108D0 (ja)
WO (1) WO1992000743A1 (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19606897C2 (de) * 1996-02-13 2002-08-29 Geistlich Soehne Ag Mittel zur Verhinderung der Tumorzellverschleppung und der Entstehung von Trokarmetastasen in der offenen und laparoskopischen Chirurgie maligner Tumoren
US20030027818A1 (en) 2001-04-03 2003-02-06 Redmond H. Paul Treatment of cancers
GB9716219D0 (en) * 1997-07-31 1997-10-08 Geistlich Soehne Ag Prevention of metastases
US6479481B1 (en) * 1999-06-04 2002-11-12 Ed. Geistlich Soehne Ag Fur Chemische Industrie Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)
US8304390B2 (en) 1997-07-31 2012-11-06 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Method of treatment for preventing or reducing tumor growth in the liver of patient
US7151099B2 (en) 1998-07-31 2006-12-19 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Use of taurolidine and/or taurultam for treatment of abdominal cancer and/or for the prevention of metastases
US7892530B2 (en) 1999-06-04 2011-02-22 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of tumor metastases and cancer
US8030301B2 (en) 1999-06-04 2011-10-04 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of cancers with methylol-containing compounds and at least one electrolyte
US7345039B2 (en) 1999-06-04 2008-03-18 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
ATE339207T1 (de) * 1999-12-06 2006-10-15 Rhode Island Hospital Verwendung von taurolidin oder taurultam zur herstellung eines medikaments zur behandlung von ovarialkarzinomen
EP1797884B1 (en) * 1999-12-06 2013-09-11 Geistlich Pharma AG Taurolidine or taurultam for use in the treatment of tumors of the prostate, colon, lung and for the treatment of recurrent glioblastoma multiforme
CN100519525C (zh) 1999-12-06 2009-07-29 葛兰素集团有限公司 芳香砜类及其医疗用途
US6641571B2 (en) 2000-01-05 2003-11-04 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Reduction of postoperative complications of cardiopulmonary bypass (CPB) surgery
AU779362B2 (en) * 2000-10-27 2005-01-20 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of tumor metastases and cancer
CA2363973C (en) * 2000-11-28 2009-03-10 Ed. Geistlich Sohne Ag Fur Chemische Industrie Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
CA2441016A1 (en) * 2001-03-15 2002-09-26 Paul Calabresi Taurine compounds
AU2002362459B2 (en) 2001-10-01 2007-08-02 Geistlich Pharma Ag Methods of inhibiting metastases
AU2004201264B2 (en) 2003-03-28 2009-12-24 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Adhesive Antineoplastic Compositions
US8236794B2 (en) 2003-09-29 2012-08-07 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of mesothelioma
EP2061429A2 (en) * 2006-09-07 2009-05-27 Ed. Geistlich Söhne Ag Für Chemische Industrie Method of treating bone cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8328073D0 (en) * 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compounds

Also Published As

Publication number Publication date
EP0491018A1 (en) 1992-06-24
JP3465824B2 (ja) 2003-11-10
WO1992000743A1 (en) 1992-01-23
JPH05500973A (ja) 1993-02-25

Similar Documents

Publication Publication Date Title
GB9005856D0 (en) Compositions
GB9015108D0 (en) Chemical compositions
GB9007074D0 (en) Novel compositions
GB9002184D0 (en) New compositions
GB9015822D0 (en) Compositions
GB9113588D0 (en) Compositions
GB9021325D0 (en) Chemical composition
GB9008433D0 (en) Novel compositions
EP0452632A3 (en) Dichloro-pentafluoropropanes-containing compositions
GB9024924D0 (en) Novel compositions
GB9004832D0 (en) Compositions
HU900262D0 (en) Oralhygenic compositions
GB8820578D0 (en) Chemical compositions
GB9221581D0 (en) Chemical compositions
GB9211109D0 (en) Chemical compositions
GB8918568D0 (en) Chemical compositions
GB9012300D0 (en) Compositions
IE900953L (en) Compositions
GB9001626D0 (en) Compositions
GB9018605D0 (en) Compositions
GB9018606D0 (en) Compositions
GB9021364D0 (en) Ore-filled compositions
GB9001200D0 (en) Compositions
GB9014768D0 (en) Compositions
GB9014709D0 (en) Compositions